Browse Contents
Select Volume:  

Select Issue:  

Select Article:


Special Offers


Articles submitted between January 01st to 30th June, 2018 will be published as Open Access. Open Access publishing provides greater accessibility to the article. To view some of the Open access articles in the journal, please click here



Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.



30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published. Multiple issue copies at discounted rates.



Abstracted/Indexed in




Forthcoming Special Issues

Strategies and Methods to Prevent Fluoropyrimidine-Associated Toxicities


Guest Editor(s): Antonello Di Paolo
Tentative Publication Date: October, 2017
Submit Abstract via Email Download Description
Published Special Issues

Personalized Therapy in Cancer of Digestive System


Guest Editor(s): Nelson S. Yee

Authors' Comments

Clinical Cancer Drugs

,

Volume 4

-

Number 2



Editorial





Review Article

Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 1 – Where Do We Stand?

, 4(2): 74 - 81

Manon Launay, Joseph Ciccolini*, Anne Rodallec, Claire Fournel, Florence Duffaud, Sebastien Salas and Bruno Lacarelle


DOI: 10.2174/2212697X04666170531080625






Review Article

Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World

, 4(2): 82 - 92

Antonello Di Paolo*, Marzia Del Re, Elena Arrigoni, Teresa Di Desidero, Eleonora Rofi, Romano Danesi and Guido Bocci


DOI: 10.2174/2212697X04666170817124625






Review Article





Review Article





Research Article

Prevention of Capecitabine Toxicity Using a 5-FU Test Dose

, 4(2): 112 - 121

Teresa Di Desidero, Cecilia Barbara, Paola Orlandi, Anna Fioravanti, Fotios Loupakis, Chiara Cremolini, Giacomo Allegrini, Antonello Di Paolo, Alfredo Falcone, Romano Danesi and Guido Bocci*


DOI: 10.2174/2212697X04666170504144550






Research Article

Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 2- Application to Head-and-Neck Cancer Patients

, 4(2): 122 - 128

Manon Launay, Joseph Ciccolini*, Claire Fournel, Charlotte Dupuis, Nicolas Fakhry, Florence Duffaud, Sebastien Salas and Bruno Lacarelle


DOI: 10.2174/2212697X04666170817123425






Review Article





Arachidonic Acid Induces the Migration of MDA-MB-231 Cells 1 by Activating Raft-associated Leukotriene B4 Receptors


Siddhartha Das*, Atasi De Chatterjee, Rituraj Pal, Debarshi Roy, Mahesh Narayan, Sukla Roychowdhury and Priscilla Guevara


View Abstract


Prevalence of Neuropathy Associated With Bortezomib: A Retrospective Study

, 2017; 4(1): 69 - 72

Pulivarthi Swaroopa, Mathew Josy, Ehresmann Kirsten and Gurram Murali Krishna*


DOI: 10.2174/2212697X03666161128102453



Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy

, 2015; 2(1): 61 - 70

Kelly Lien, Michelle Rocha, Elisa Tran, Van C. Hoang, Annabelle Chow and Urban Emmenegger


DOI: 10.2174/2212697X02666150331202809



Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy

, 2014; 1(2): 116 - 126

Annabelle Chow, Giulio Francia, Andrew Kouri, Christina Lee, John M. Ebos, Robert S. Kerbel and Urban Emmenegger


DOI: 10.2174/2212697X01666131218235200



The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment

, 2014; 1(1): 65 - 71

Bianca Maria Veneziani, Micaela Montanari, Maria Letizia Cataldo, Luigi Coppola, Agostina Nardone, Sara Corvigno, Carmine De Angelis, Grazia Arpino, Mario Giuliano, Chiara Carlomagno, Roberto Bianco and Sabino De Placido


DOI: 10.2174/2212697X113016660008



Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science